CNN’s Meg Tirrell sits down with Johnny Lubin, one of the first in the world to try a new kind of medicine that uses a gene-editing tool called CRISPR to offer a potential cure for sickle cell disease.
The Trump administration's reductions in medical care and research funding have led to significant disruptions at the National Cancer Institute, including the cessation of research funding, staff reductions, and communication limitations, potentially hindering advancements in cancer treatment.